home.aspx
 
EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

BJC HealthCare

BJC HealthCare is one of the largest nonprofit health care organizations in the United States, and is focused on delivering services to residents primarily in the greater St. Louis, southern Illinois and mid-Missouri regions. BJC HealthCare has ranked as one of the top workplaces among large employers in the seventh annual St. Louis Post-Dispatch Top Workplaces for 2018 program. BJC is one of 150 Greater St. Louis employers to receive the award and the only health care system to make the list.

RELATED NEWS


A study published by The BMJ has reported a possible association between higher consumption of sugary drinks and and an increased risk of cancer. The data comes from a team of researchers based in France, who set out to assess the associations between the consumption of sugary drinks (sugar sweetened beverages and 100% fruit juices), artificially sweetened beverages, and risk of overall cancer, as well as breast, prostate, and bowel cancers. The results show that a 100 ml per day increase in the...

READ MORE

NEW DELHI: Pharma stocks were anyway on the investor radar. Now, fresh concerns over US prosecutors’ fresh criminal investigation into suspected collusion among global generic pharma companies for price manipulation have turned things worse for the pharma stocks....
ECONOMICTIMES.INDIATIMES.COM
READ MORE

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to specialist clinics. The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential breakthrough in depression treatment, despite safety concerns arising from the fact that the anesthetic is commonly abused as a recreational drug. It works o...

READ MORE

Verseau Therapeutics has launched to develop immunotherapies that act as checkpoint modulators of macrophages, inducing an immune response against cancer. The company received a $50m investment from 3SBio, 20 / 20 HealthCare Partners, Yonghua Capital, The Mark Foundation for Cancer Research, InHarv Partners, Highlight Capital and Alexandria Venture Investments. Verseau Therapeutics will use the funds to advance macrophage checkpoint modulator (MCM) programmes into the clinic. Macrophages exhibit...

READ MORE

The health blockchain technology firm Witty Health has launched OncoPower, a digital tool helping oncologists with their decision making. OncoPower helps oncologists create a de-identified case study with details like co-morbidity, specific cancer type, lines of therapy, and actual drugs used for treatment. It then rates the effectiveness of those drugs and publishes the data on the fly in minutes. The purpose of the tool is to assess if drugs safely and effectively improve a patient’s hea...

READ MORE

BiondVax may be operating in a flu vaccine field occupied by global giants, but that isn't stopping the Israeli biotech from pressing ahead with what it says is the world's most advanced universal flu vaccine candidate. The company recently signed a phase 3 trial agreement with a contract research organization with eyes on reaching the market quickly after the study wraps up, CEO Ron Babecoff told FiercePharma. The two-year trial in eastern European countries will test the vaccine, M-001...
FIERCEPHARMA
READ MORE

EVENTS

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...